SPTBN4 抗体 (C-Term)
Quick Overview for SPTBN4 抗体 (C-Term) (ABIN2115264)
抗原
See all SPTBN4 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 1621-1832, C-Term
- 
                                            纯化方法
- Tissue Culture Supernatant
- 
                                            免疫原
- Fusion protein AA 1621-1832 (C-terminal repeats 14 to 15) of human Beta4-spectrin (also known as BetaIV-spectrin sigma1, Nonerythrocytic spectrin beta chain 4, Non-erythroid spectrin beta chain 3, SPTBN4, SPTBN3, Spnb4, KIAA1642, EMBL BAB83243.1 and Ensembl ENSRNOP00000028393, accession number Q9H254)
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 1:2-1:20 immunoperoxidase-based immunohistochemistry, 1:2-1:10 immunofluorescence-based immunohistochemistry
- 
                                            说明
- 
                        TC Supernatant: conditioned bovine serum-containing media harvested from hybridomas cultured in vitro. Typically contains 20-40 μg/mL mouse monoclonal IgG plus bovine IgG and other bovine serum components. Can contain much higher amounts of mouse monoclonal IgG and be a better value than Purified IgG. 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 20-40 μg/mL
 
- 
                                            
- 
    - SPTBN4 (Spectrin Beta, Non-Erythrocytic 4 (SPTBN4))
- 
                                            别名
- Beta4-Spectrin
- 
                                            分子量
- >200 kDa
- 
                                            UniProt
- Q9H254
- 
                                            途径
- Sensory Perception of Sound, Regulation of Actin Filament Polymerization, Maintenance of Protein Location
 抗原
- 
                    
 
                                     
                                     
                                    